Inhibitors of checkpoint kinases

Details for Australian Patent Application No. 2006324144 (hide)

Owner Merck & Co., Inc.

Inventors Steen, Justin T.; Garbaccio, Robert M.; Huaung, Shaei Y.; Fraley, Mark E.

Agent Spruson & Ferguson

Pub. Number AU-A-2006324144

Priority 60/647,997 28.01.05 US

Filing date 24 January 2006

Wipo publication date 2 August 2007

International Classifications

C12N 15/00 (2006.01) Mutation or genetic engineering

Event Publications

2 August 2007 Application Open to Public Inspection

  Published as AU-A-2006324144

2 August 2007 PCT application entered the National Phase

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

18 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006324147-Nickel alloy and method of direct aging heat treatment

2006324143-Method for continuous casting and rolling at increased casting speed followed by hot rolling of relatively thin metal strands, especially steel strands, and a continuous casting and rolling installation